# MICROCRYSTALLINE CELLULOSE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid3050492
Categories: cleaning, industrial, pharma
Functions: Abrasive, Absorbent, Anti-adhesive/cohesive, Anti-caking agent, Binder, Emulsifier, Filler, Opacifer, Stabilizing agent, Surfactant (surface active agent), Thickening agent, Viscosity modifier
Identifier: DTXSID3050492

> MICROCRYSTALLINE CELLULOSE is used as abrasive / absorbent. EPA CPDat observed this chemical in 1631 composition records across product categories including Cleaning and safety, Industrial products, Construction and building materials. Assessed from 56 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 1631 composition records across product categories including Cleaning and safety, Industrial products, Construction and building materials.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 1631 composition records across product categories including Cleaning and safety, Industrial products, Construction and building materials. EPA CPDat classifies this chemical for functional uses including Abrasive, Absorbent, Emulsifier.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 18 mg
- US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: IMPLANT; Potency: 1.66 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 2169 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Maximum daily exposure: 456 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 366 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 1246 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 29520 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, DELAYED RELEASE; Potency: 789.6 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 278 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 1140 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 690 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 4441 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 1600 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 1120 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 5117 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 1725 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 144 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 920 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 2210 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE PARTICLES; Maximum daily exposure: 580 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 5119 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 992 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 615 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 20100 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 1800 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 1576 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TROCHE; Maximum daily exposure: 300 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 43.2 mg
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Potency: 4.5 mg
- US: inactive ingredient database — Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: NA
- US: inactive ingredient database — Route: EXTRACORPOREAL; Dosage form: DISC; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 2430 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: DROPS; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: LIQUID; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 1600 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 1582 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 40.2 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 16 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 156 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 392 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 4.5 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: DISC; Potency: NA
- US: marketed drug occurrence — FDA NDC lists this ingredient in 1 active drug products and 1 total products.
- US: marketed drug occurrence — FDA NDC lists this ingredient in 1 active drug products and 4 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as polymer.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as concept.

_Assessed by Greenveil._